IMAPAC Glossary

Juvenile toxicity patterns describe age-specific toxicological responses observed in immature animals during non-clinical safety studies.

A juvenile toxicity study is a non-clinical safety study that evaluates the effects of a therapeutic product on the growth and development of immature animals.

Kaplan-Meier survival analysis is a statistical method used to estimate survival probabilities over time while accounting for censored observations in clinical studies.

A kappa light chain is one of the two classes of immunoglobulin light chains that forms part of the structure and antigen-binding region of antibodies.

A karyotype is the complete visual representation of an organism's chromosomes used to evaluate chromosome number, structure and genetic abnormalities.

Karyotype analysis validation demonstrates that chromosomal analysis methods consistently produce accurate, reliable and reproducible genetic results.

A keratinocyte is the predominant cell type of the epidermis that produces keratin and forms the protective outer barrier of the skin.

Ketone body metabolism comprises the biochemical pathways responsible for the production, utilisation and regulation of ketone bodies as alternative energy sources.

A Key Opinion Leader (KOL) is a recognised scientific or clinical expert whose knowledge and influence help shape research, clinical practice and healthcare decisions.

A Key Performance Indicator (KPI) is a measurable metric used to evaluate the performance, progress or success of a process, project or organisation.

Kidney clearance is the process by which the kidneys remove drugs, metabolites or other substances from the bloodstream through filtration and excretion.

Kidney function assessment biomarkers are measurable biological indicators used to evaluate renal function, kidney injury and disease progression.

Kidney Injury Molecule-1 (KIM-1) is a biomarker of renal tubular injury used to detect, monitor and assess drug-induced kidney damage.

Kidney tissue distribution evaluates the extent and pattern of therapeutic compound localisation within renal tissues following administration.

Kidney toxicity is damage to kidney structure or function caused by drugs, chemicals or biological agents, potentially impairing renal performance.

A killed vaccine is a vaccine containing inactivated pathogens that cannot replicate but retain the ability to stimulate protective immune responses.

A kinase is an enzyme that transfers phosphate groups to proteins or other molecules, regulating signalling pathways and numerous cellular processes.

Kinase inhibitor selectivity measures the ability of a kinase inhibitor to specifically target intended kinases while minimising off-target activity.

A kinetic binding assay measures the rate and strength of molecular interactions by determining the association and dissociation of binding partners over time.

Kinetic model development creates mathematical models that describe the rates and mechanisms of biological, chemical or pharmacokinetic processes.

Kinetic modelling uses mathematical models to describe, predict and optimise the rates of biological, chemical or pharmacokinetic processes.

Kinetic proofreading is a biological mechanism that improves molecular recognition accuracy by using energy-dependent steps to reduce incorrect binding events.

Kinetics is the study of the rates and mechanisms of biological, chemical or physical processes and how they change over time.

Kinetics of release describes the rate and mechanism by which an active ingredient is released from a formulation or delivery system over time.

Kinetic solubility is the apparent solubility of a compound measured before equilibrium is reached, reflecting its dissolution behaviour under experimental conditions.

Kinetic solubility measurement determines the apparent solubility of a compound before equilibrium is reached, supporting formulation and drug discovery decisions.

Kinetic stability describes the resistance of a molecule or formulation to structural or chemical change over time despite not necessarily being at thermodynamic equilibrium.

A kinetochore is a protein complex assembled on chromosomes that attaches them to spindle microtubules during cell division to ensure accurate chromosome segregation.

Knockdown is the experimental reduction of gene expression without completely eliminating gene function, commonly achieved using RNA interference or related technologies.

Knockin is a genetic engineering technique that inserts specific DNA sequences into a defined genomic location to introduce or modify gene function.

A knockout mouse is a genetically engineered mouse in which a specific gene has been permanently inactivated to study its biological function.

Knowledge management is the systematic process of capturing, organising, sharing and applying information to improve organisational learning and decision-making.

Knowledge translation implementation converts scientific evidence into practical clinical, regulatory or public health applications to improve healthcare outcomes.

Label expansion is the regulatory approval of additional indications, populations, dosing regimens or uses for an already authorised therapeutic product.

A Laboratory Developed Test (LDT) is a diagnostic assay designed, validated and performed within a single clinical laboratory for patient testing.

Laboratory quality assurance comprises the planned systems and procedures that ensure laboratory activities consistently produce accurate, reliable and reproducible results.

Lactate dehydrogenase (LDH) is an intracellular enzyme released during tissue damage and widely used as a biomarker of cell injury and cytotoxicity.

A latent viral reservoir is a population of infected cells that harbour dormant virus capable of reactivation despite antiviral therapy.

A lead compound is a promising chemical or biological candidate with demonstrated activity that serves as the starting point for drug development.

Lead identification is the drug discovery process of finding compounds with sufficient biological activity to progress into optimisation.

Lead optimisation is the process of refining lead compounds to improve potency, selectivity, pharmacokinetics and safety before clinical development.

A lentiviral vector is an engineered lentivirus used to deliver genetic material into target cells for research, gene therapy and cell engineering.

A lentivirus is a genus of retroviruses capable of integrating genetic material into host cells and commonly used in gene delivery applications.

A ligand is a molecule that specifically binds to a receptor, protein or other biological target to influence its biological activity.

A ligand binding assay is an analytical method that measures the interaction between a ligand and its target molecule for research, development or quality testing.

Ligand-protein interaction thermodynamics characterises the energetic forces governing molecular binding, including enthalpy, entropy and binding affinity.

A lipase is an enzyme that catalyses the breakdown of lipids into fatty acids and glycerol during digestion and metabolism.

Lipidation is the covalent attachment of lipid molecules to proteins or peptides to modify their stability, localisation or biological activity.

A lipid nanoparticle (LNP) is a lipid-based delivery system that encapsulates and protects nucleic acids, enabling efficient intracellular delivery.

Lipophilicity optimisation adjusts the hydrophobic properties of drug candidates to improve absorption, distribution, efficacy and pharmacokinetic performance.

A liposome is a spherical vesicle composed of lipid bilayers that encapsulates therapeutic agents to improve drug delivery and stability.

A liquid biopsy is a minimally invasive test that analyses circulating biomarkers in body fluids to detect or monitor disease.

Liver microsomal metabolism studies evaluate how hepatic microsomal enzymes metabolise therapeutic compounds to predict clearance and drug interactions.

A loading dose is an initial higher dose of a medicine administered to rapidly achieve the desired therapeutic concentration in the body.

Loading dose calculation determines the initial medicine dose required to rapidly achieve the desired therapeutic concentration within the body.

Local tolerance is the ability of a formulation or therapeutic product to be administered at a specific site without causing unacceptable local adverse reactions.

LogP is the logarithm of a compound's partition coefficient between octanol and water, indicating its lipophilicity.

Longitudinal data analysis evaluates repeated measurements collected over time to identify trends, treatment effects and changes within study populations.

A long-term safety database compiles extended clinical safety information to evaluate the ongoing risk profile of a therapeutic product.

Long-term stability is the ability of a pharmaceutical product to maintain its quality, safety and efficacy throughout its intended storage period.

Loss of taste sensation, or ageusia, is the partial or complete inability to perceive taste that may occur as a disease symptom or treatment-related adverse effect.

The lymphocyte transformation test measures lymphocyte proliferation following antigen exposure to assess cellular immune responses or drug hypersensitivity.

Lyophilisation is a freeze-drying process that removes water by sublimation to improve the stability and shelf life of pharmaceutical products.

Lyophilisation process optimisation refines freeze-drying parameters to maximise product stability, manufacturing efficiency and pharmaceutical quality.

Lyophilise means to remove water from a frozen material by sublimation under reduced pressure to preserve its biological activity and structural integrity.

A lysate is a preparation containing the contents of disrupted cells used for biological research, analytical testing or biopharmaceutical manufacturing.

A macrophage is a specialised immune cell that engulfs pathogens, presents antigens and regulates inflammation, tissue repair and immune responses throughout the body.

A magnetic resonance imaging (MRI) biomarker is an imaging-derived measurement used to evaluate disease status, progression or therapeutic response.

Market authorisation is the regulatory approval allowing a medicinal product to be commercially marketed after demonstrating its quality, safety and efficacy.

A Master Cell Bank (MCB) is a fully characterised collection of cryopreserved cells that serves as the primary source for consistent biopharmaceutical manufacturing.

The maximum recommended dose is the highest dose considered acceptable based on clinical evidence of safety, tolerability and therapeutic benefit.

Mechanism of Action (MOA) describes the specific biological process through which a therapeutic product produces its intended pharmacological effect.

Mechanistic target engagement demonstrates that a therapeutic product successfully interacts with its intended biological target to produce the desired pharmacological effect.

Mediastinal mass assessment evaluates abnormal tissue growth within the mediastinum using imaging, pathology and clinical investigations to support diagnosis and treatment.

Membrane transporter expression evaluates the presence and activity of transport proteins that regulate the movement of molecules across biological membranes.

Metabolite identification studies detect and characterise metabolites formed during drug metabolism to support safety, efficacy and regulatory evaluation.

Metabolomics is the comprehensive study of small-molecule metabolites within biological systems to understand physiological processes, disease mechanisms and therapeutic responses.

Metastasis is the process by which cancer cells spread from the primary tumour to distant tissues and establish secondary tumours.

A microarray is a high-throughput analytical platform that simultaneously measures the expression or presence of thousands of genes or biomolecules.

A microbiological limit test determines whether pharmaceutical products comply with predefined limits for microbial contamination and specified microorganisms.

The microbiota is the community of microorganisms that naturally inhabit a specific environment, such as the human gut, skin or respiratory tract.

A microcarrier is a small support particle used to grow adherent cells in suspension bioreactors for large-scale cell culture.

Microfluidics is the manipulation of minute fluid volumes within microscale channels for analytical, diagnostic and biopharmaceutical applications.

A microneedle is a microscopic needle designed to deliver drugs or vaccines through the skin with minimal pain and tissue damage.

A microsphere is a spherical microparticle used to encapsulate and deliver therapeutic agents in a controlled and sustained manner.

Minimal Residual Disease (MRD) is the small number of cancer cells that remain after treatment and may lead to disease relapse.

Mitochondrial toxicity is cellular damage caused by disruption of mitochondrial function, potentially impairing energy production and causing adverse drug effects.

Mitogen-Activated Protein Kinase (MAPK) is a signalling pathway that regulates cell growth, differentiation, survival and responses to external stimuli.

Mixed-mode chromatography is a purification technique that combines multiple separation mechanisms, such as ionic and hydrophobic interactions, within a single chromatography medium.

A molecular biomarker is a measurable biological molecule that indicates normal biological processes, disease states or responses to therapeutic intervention.

Molecular docking is a computational technique that predicts how a molecule binds to its biological target and estimates the strength of the interaction.

Molecular docking simulation uses computational modelling to predict how a molecule binds to its biological target and estimate binding interactions.

Molecular dynamics is a computational simulation method that models the movement and interactions of atoms and molecules over time.

Molecular weight consideration evaluates how molecular size influences drug absorption, distribution, clearance and formulation characteristics.

A monoclonal antibody is a laboratory-produced antibody that specifically recognises a single target antigen for therapeutic, diagnostic or research applications.

Monoclonal gammopathy is a condition characterised by the abnormal production of a single monoclonal immunoglobulin by a clone of plasma cells.

A monocyte is a circulating white blood cell that differentiates into macrophages or dendritic cells to support innate and adaptive immunity.

A monograph is an official document defining the quality standards, specifications and testing requirements for a pharmaceutical substance or product.

mRNA therapy uses messenger RNA to direct cells to produce therapeutic proteins for the prevention or treatment of disease.

Mucosal immunity is the immune protection provided at mucosal surfaces through specialised immune cells, antibodies and local defence mechanisms.